← Leaderboards
Ann Donoghue
Vetdc, Inc.
$337,500
Attributed
$337,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $150K · FY2018–20$200K$150K$100K$50K$0
'18
'19
'20
Funding mix
By agency
FDA$337,500 · 1
By mechanism
R01$337,500 · 1
Top collaborators
No co-investigators on record.
Grant awards (3)
A randomized, blinded, placebo-controlled field study to determine the efficacy and safety of TANOVEA-CA1 (rabacfosadine for injection) in dogs. Protocol Number VC-014.$37,500
R01 · FY2020 · FD · contact PI
A randomized, blinded, placebo-controlled field study to determine the efficacy and safety of TANOVEA-CA1 (rabacfosadine for injection) in dogs. Protocol Number VC-014.$150,000
R01 · FY2019 · FD · contact PI
A randomized, blinded, placebo-controlled field study to determine the efficacy and safety of TANOVEA-CA1 (rabacfosadine for injection) in dogs. Protocol Number VC-014.$150,000
R01 · FY2018 · FD · contact PI